#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	18554	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2271	814.1	1	SNP	n	C1184T	0	.	.	1184	1184	C	1462	1462	C	1061	C,T,G	955,1,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	33120	23S	2890	2890	99.9	23S.l6.c17.ctg.1	3506	941.6	0	.	n	.	0	T695C	SNP	695	695	T	982	982	C	1090	C,T,A	998,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	33120	23S	2890	2890	99.9	23S.l6.c17.ctg.1	3506	941.6	0	.	n	.	0	G1337A	SNP	1337	1337	G	1624	1624	A	1161	A	1041	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	33120	23S	2890	2890	99.9	23S.l6.c17.ctg.1	3506	941.6	0	.	n	.	0	T1971C	SNP	1971	1971	T	2258	2258	C	1092	C	983	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	33120	23S	2890	2890	99.9	23S.l6.c17.ctg.1	3506	941.6	1	SNP	n	A2045G	0	.	.	2045	2045	A	2332	2332	A	1041	A	968	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	33120	23S	2890	2890	99.9	23S.l6.c17.ctg.1	3506	941.6	1	SNP	n	C2597T	0	.	.	2597	2597	C	2884	2884	C	1054	C,T	978,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_L_00516	folP.WHO_L_00516	1	1	27	2446	folP	855	855	100.0	folP.l15.c4.ctg.1	1504	161.9	1	SNP	p	R229S	0	.	.	685	687	CGC	966	968	CGC	240;243;245	C;G;C	220;221;222	folP.WHO_L_00516:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	6380	gyrA	2751	2751	99.89	gyrA.l6.c4.ctg.1	3263	194.8	1	SNP	p	S91F	0	.	.	271	273	TCC	543	545	TCC	215;215;214	T;C;C	197;198;198	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	6380	gyrA	2751	2751	99.89	gyrA.l6.c4.ctg.1	3263	194.8	1	SNP	p	D95G	0	.	.	283	285	GAC	555	557	GAC	206;207;205	G;A;C	188;185;186	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	6380	gyrA	2751	2751	99.89	gyrA.l6.c4.ctg.1	3263	194.8	1	SNP	p	D95N	0	.	.	283	285	GAC	555	557	GAC	206;207;205	G;A;C	188;185;186	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_W_01449	mtrR.WHO_W_01449	1	1	27	1950	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1216	159.5	1	SNP	p	G45D	1	.	.	133	135	GAC	455	457	GAC	245;245;247	G;A;C	227;224;231	mtrR.WHO_W_01449:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	1022	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	966	105.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	27	6138	parC	2304	2304	99.83	parC.l15.c4.ctg.1	2926	209.0	1	SNP	p	D86N	0	.	.	256	258	GAC	530	532	GAC	239;241;242	G,C;A;C	213,1;215;214	parC.WHO_V_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	27	6138	parC	2304	2304	99.83	parC.l15.c4.ctg.1	2926	209.0	1	SNP	p	S88P	0	.	.	262	264	TCC	536	538	TCC	239;239;235	T;C;C	209;211;211	parC.WHO_V_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	5208	parE	1986	1986	100.0	parE.l15.c30.ctg.1	2730	189.9	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1534	1536	GGC	236;238;239	G;G;C	210;211;210	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.9.001	penA.9.001	1	1	27	4862	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2460	196.8	1	SNP	p	A311V	0	.	.	931	933	GCA	1335	1337	GCA	270;271;271	G,A;C;A	240,1;236;242	penA.9.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4862	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2460	196.8	1	SNP	p	I312M	0	.	.	934	936	ATC	1338	1340	ATC	268;271;272	A;T;C	235;240;240	penA.9.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4862	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2460	196.8	1	SNP	p	V316T	0	.	.	946	948	GTG	1350	1352	GTG	278;277;278	G;T,C;G	242;237,1;247	penA.9.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4862	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2460	196.8	1	SNP	p	V316P	0	.	.	946	948	GTG	1350	1352	GTG	278;277;278	G;T,C;G	242;237,1;247	penA.9.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4862	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2460	196.8	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1854	1856	ACC	267;266;265	A;C;C	232;236;235	penA.9.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4862	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2460	196.8	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1908	1910	GCG	256;257;255	G;C;G	224;208;215	penA.9.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4862	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2460	196.8	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1908	1910	GCG	256;257;255	G;C;G	224;208;215	penA.9.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4862	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2460	196.8	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2031	2033	GGC	207;205;206	G;G;C	182;179;183	penA.9.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4862	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2460	196.8	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2040	2042	GGC	204;203;206	G,A;G;C	177,1;181;180	penA.9.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4862	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2460	196.8	1	SNP	p	L552S	0	.	.	1654	1656	CTG	2058	2060	CTG	199;202;202	C,G;T;G	146,5;146;151	penA.9.001:1:1:L552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	539	7068	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3058	230.6	1	SNP	p	L421P	1	L421P	NONSYN	1261	1263	CTG	1607	1609	CCG	267;265;271	C;C;G	227;232;234	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2596	porA	1146	1146	99.83	porA.l15.c30.ctg.1	1657	155.6	0	.	p	.	0	S22G	NONSYN	64	66	AGC	278	280	GGC	175;174;172	G;G;C	152;154;153	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2596	porA	1146	1146	99.83	porA.l15.c30.ctg.1	1657	155.6	0	.	p	.	0	M83fs	FSHIFT	247	247	A	460	460	C	194	C	175	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	416	porB1a	984	273	91.21	porB1a.l15.c30.ctg.2	416	48.4	0	.	p	.	0	Y273D	NONSYN	817	819	TAT	171	173	GAT	88;87;83	G;A;T	75;74;72	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	416	porB1a	984	273	91.21	porB1a.l15.c30.ctg.2	416	48.4	0	.	p	.	0	D274S	NONSYN	820	822	GAT	174	176	AGT	83;85;86	A;G;T	71;71;72	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	416	porB1a	984	273	91.21	porB1a.l15.c30.ctg.2	416	48.4	0	.	p	.	0	D276N	NONSYN	826	828	GAT	180	182	AAC	85;85;85	A;A;C	73;72;72	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	416	porB1a	984	273	91.21	porB1a.l15.c30.ctg.2	416	48.4	0	.	p	.	0	N277H	NONSYN	829	831	AAC	183	185	CAC	85;85;84	C;A;C	73;73;73	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	416	porB1a	984	273	91.21	porB1a.l15.c30.ctg.2	416	48.4	0	.	p	.	0	R307E	NONSYN	919	921	AGA	273	275	GAA	28;28;27	G;A;A	27;27;26	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	416	porB1a	984	273	91.21	porB1a.l15.c30.ctg.2	416	48.4	0	.	p	.	0	T311A	NONSYN	931	933	ACA	285	287	GCA	27;27;27	G;C;A	27;27;27	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	416	porB1a	984	273	91.21	porB1a.l15.c30.ctg.2	416	48.4	0	.	p	.	0	E312D	NONSYN	934	936	GAA	288	290	GAC	27;26;25	G;A;C	27;25;25	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	416	porB1a	984	273	91.21	porB1a.l15.c30.ctg.2	416	48.4	0	.	p	.	0	F314I	NONSYN	940	942	TTC	294	296	ATC	26;26;24	A;T;C	26;25;24	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	416	porB1a	984	273	91.21	porB1a.l15.c30.ctg.2	416	48.4	0	.	p	.	0	A316S	NONSYN	946	948	GCG	300	302	TCG	23;23;23	T;C;G	22;23;23	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	416	porB1a	984	273	91.21	porB1a.l15.c30.ctg.2	416	48.4	0	.	p	.	0	V318A	NONSYN	952	954	GTC	306	308	GCC	21;22;22	G;C;C	20;22;22	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	416	porB1a	984	273	91.21	porB1a.l15.c30.ctg.2	416	48.4	0	.	p	.	0	G319S	NONSYN	955	957	GGC	309	311	AGC	21;21;21	A;G;C	21;20;21	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	416	porB1a	984	273	91.21	porB1a.l15.c30.ctg.2	416	48.4	0	.	p	.	0	G320A	NONSYN	958	960	GGT	312	314	GCC	21;21;21	G;C;C	21;21;21	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	416	porB1a	984	273	91.21	porB1a.l15.c30.ctg.2	416	48.4	0	.	p	.	0	G322V	NONSYN	964	966	GGT	318	320	GTT	21;21;21	G;T;T	20;21;21	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3268	porB1b	1047	1047	96.87	porB1b.l6.c4.ctg.1	1571	207.0	0	.	p	.	0	G38E	NONSYN	112	114	GGA	416	418	GAA	302;302;303	G;A;A	271;272;270	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3268	porB1b	1047	1047	96.87	porB1b.l6.c4.ctg.1	1571	207.0	0	.	p	.	0	K120D	NONSYN	358	360	AAG	662	664	GAC	261;259;262	G;A;C	236;233;238	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3268	porB1b	1047	1047	96.87	porB1b.l6.c4.ctg.1	1571	207.0	0	.	p	.	0	G140K	NONSYN	418	420	GGA	722	724	AAA	271;269;271	A;A;A	252;250;251	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3268	porB1b	1047	1047	96.87	porB1b.l6.c4.ctg.1	1571	207.0	0	.	p	.	0	K143E	NONSYN	427	429	AAA	731	733	GAA	264;271;270	G;A;A,T	240;247;248,1	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3268	porB1b	1047	1047	96.87	porB1b.l6.c4.ctg.1	1571	207.0	0	.	p	.	0	Q187R	NONSYN	559	561	CAA	863	865	CGA	262;259;262	C;G;A	247;243;247	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3268	porB1b	1047	1047	96.87	porB1b.l6.c4.ctg.1	1571	207.0	0	.	p	.	0	S189G	NONSYN	565	567	AGC	869	871	GGC	270;273;273	G;G;C	249;251;246	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3268	porB1b	1047	1047	96.87	porB1b.l6.c4.ctg.1	1571	207.0	0	.	p	.	0	N212D	NONSYN	634	636	AAT	938	940	GAT	247;248;250	G;A;T	225;226;229	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3268	porB1b	1047	1047	96.87	porB1b.l6.c4.ctg.1	1571	207.0	0	.	p	.	0	D213N	NONSYN	637	639	GAT	941	943	AAT	248;245;243	A;A;T	232;230;225	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3268	porB1b	1047	1047	96.87	porB1b.l6.c4.ctg.1	1571	207.0	0	.	p	.	0	T215S	NONSYN	643	645	ACT	947	949	TCT	246;249;254	T,G;C;T	222,1;226;237	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3268	porB1b	1047	1047	96.87	porB1b.l6.c4.ctg.1	1571	207.0	0	.	p	.	0	G255Q	NONSYN	763	765	GGA	1067	1069	CAA	226;225;222	C;A;A	212;211;211	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3268	porB1b	1047	1047	96.87	porB1b.l6.c4.ctg.1	1571	207.0	0	.	p	.	0	.	INDELS	766	768	ACA	1071	1075	ATCAA	213;210;213;215;216	A;T;C;A;A	202;196;199;201;203	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3268	porB1b	1047	1047	96.87	porB1b.l6.c4.ctg.1	1571	207.0	0	.	p	.	0	.	INDELS	769	770	TG	1078	1080	AGT	219;219;218	A;G;T	204;204;203	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3268	porB1b	1047	1047	96.87	porB1b.l6.c4.ctg.1	1571	207.0	0	.	p	.	0	A259D	NONSYN	775	777	GCT	1085	1087	GAT	220;219;223	G;A;T	207;205;208	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3268	porB1b	1047	1047	96.87	porB1b.l6.c4.ctg.1	1571	207.0	0	.	p	.	0	L279V	NONSYN	835	837	TTA	1145	1147	GTA	232;230;229	G;T;A	209;206;206	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3268	porB1b	1047	1047	96.87	porB1b.l6.c4.ctg.1	1571	207.0	0	.	p	.	0	H294D	NONSYN	880	882	CAT	1190	1192	GAT	239;240;242	G;A;T	213;214;216	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3268	porB1b	1047	1047	96.87	porB1b.l6.c4.ctg.1	1571	207.0	0	.	p	.	0	D297N	NONSYN	889	891	GAC	1199	1201	AAC	253;253;255	A;A;C	223;222;225	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3268	porB1b	1047	1047	96.87	porB1b.l6.c4.ctg.1	1571	207.0	0	.	p	.	0	Y298H	NONSYN	892	894	TAC	1202	1204	CAC	254;253;253	C;A;C	223;219;221	.	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	13162	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4818	272.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1406	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	972	142.7	1	SNP	p	V57M	1	.	.	169	171	ATG	541	543	ATG	300;306;309	A;T;G	275;279;279	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
